Skip to main content
Top
Published in: Breast Cancer Research 5/2011

Open Access 01-10-2011 | Research article

Mammographic density and breast cancer risk: the role of the fat surrounding the fibroglandular tissue

Authors: Mariëtte Lokate, Petra HM Peeters, Linda M Peelen, Gerco Haars, Wouter B Veldhuis, Carla H van Gils

Published in: Breast Cancer Research | Issue 5/2011

Login to get access

Abstract

Introduction

Both the percent of mammographic density and absolute dense (fibroglandular) area are strong breast cancer risk factors. The role of non-dense (fat) breast tissue is not often investigated, but we hypothesize that this also influences risk. In this study we investigated the independent effects of dense and fat tissue, as well as their combined effect on postmenopausal breast cancer risk.

Methods

We performed a nested case-control study within the EPIC-NL cohort (358 postmenopausal breast cancer cases and 859 postmenopausal controls). We used multivariate logistic regression analyses to estimate breast cancer odds ratios adjusted for body mass index and other breast cancer risk factors.

Results

Large areas of dense (upper (Q5) vs lower quintile (Q1): OR 2.8 95% CI 1.7 to 4.8) and fat tissue (Q5 vs Q1: OR 2.4; 95% CI 1.3 to 4.2) were independently associated with higher breast cancer risk. The combined measure showed that the highest risk was found in women with both a large (above median) area of dense and fat tissue.

Conclusions

Fibroglandular and breast fat tissue have independent effects on breast cancer risk. The results indicate that the non-dense tissue, which represents the local breast fat, increases risk, even independent of body mass index (BMI). When studying dense breast tissue in relation to breast cancer risk, adjustment for non-dense tissue seems to change risk estimates to a larger extent than adjustment for BMI. This indicates that adjustment for non-dense tissue should be considered when studying associations between dense areas and breast cancer risk.
Literature
1.
go back to reference Vachon CM, van Gils CH, Sellers TA, Ghosh K, Pruthi S, Brandt KR, Pankratz VS: Mammographic density, breast cancer risk and risk prediction. Breast Cancer Res. 2007, 9: 217-10.1186/bcr1829.CrossRefPubMedPubMedCentral Vachon CM, van Gils CH, Sellers TA, Ghosh K, Pruthi S, Brandt KR, Pankratz VS: Mammographic density, breast cancer risk and risk prediction. Breast Cancer Res. 2007, 9: 217-10.1186/bcr1829.CrossRefPubMedPubMedCentral
2.
go back to reference McCormack VA, dos Santos Silva I: Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006, 15: 1159-1169. 10.1158/1055-9965.EPI-06-0034.CrossRefPubMed McCormack VA, dos Santos Silva I: Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006, 15: 1159-1169. 10.1158/1055-9965.EPI-06-0034.CrossRefPubMed
3.
go back to reference Ursin G, Hovanessian-Larsen L, Parisky YR, Pike MC, Wu AH: Greatly Increased occurrence of breast cancers in areas of mammographically dense tissue. Breast Cancer Res. 2005, 7: R605-R608. 10.1186/bcr1260.CrossRefPubMedPubMedCentral Ursin G, Hovanessian-Larsen L, Parisky YR, Pike MC, Wu AH: Greatly Increased occurrence of breast cancers in areas of mammographically dense tissue. Breast Cancer Res. 2005, 7: R605-R608. 10.1186/bcr1260.CrossRefPubMedPubMedCentral
4.
go back to reference Haars G, van Noord PA, van Gils CH, Grobbee DE, Peeters PH: Measurements of breast density: no ratio for a ratio. Cancer Epidemiol Biomarkers Prev. 2005, 14: 2634-2640. 10.1158/1055-9965.EPI-05-0824.CrossRefPubMed Haars G, van Noord PA, van Gils CH, Grobbee DE, Peeters PH: Measurements of breast density: no ratio for a ratio. Cancer Epidemiol Biomarkers Prev. 2005, 14: 2634-2640. 10.1158/1055-9965.EPI-05-0824.CrossRefPubMed
5.
go back to reference Maskarinec G, Meng L: A case-control study of mammographic densities in Hawaii. Breast Cancer Res Treat. 2000, 63: 153-161. 10.1023/A:1006486319848.CrossRefPubMed Maskarinec G, Meng L: A case-control study of mammographic densities in Hawaii. Breast Cancer Res Treat. 2000, 63: 153-161. 10.1023/A:1006486319848.CrossRefPubMed
6.
go back to reference Nagata C, Matsubara T, Fujita H, Nagao Y, Shibuya C, Kashiki Y, Shimizu H: Mammographic density and the risk of breast cancer in Japanese women. Br J Cancer. 2005, 92: 2102-2106. 10.1038/sj.bjc.6602643.CrossRefPubMedPubMedCentral Nagata C, Matsubara T, Fujita H, Nagao Y, Shibuya C, Kashiki Y, Shimizu H: Mammographic density and the risk of breast cancer in Japanese women. Br J Cancer. 2005, 92: 2102-2106. 10.1038/sj.bjc.6602643.CrossRefPubMedPubMedCentral
7.
go back to reference Stone J, Warren RM, Pinney E, Warwick J, Cuzick J: Determinants of percentage and area measures of mammographic density. Am J Epidemiol. 2009, 170: 1571-1578. 10.1093/aje/kwp313.CrossRefPubMed Stone J, Warren RM, Pinney E, Warwick J, Cuzick J: Determinants of percentage and area measures of mammographic density. Am J Epidemiol. 2009, 170: 1571-1578. 10.1093/aje/kwp313.CrossRefPubMed
8.
go back to reference Kato I, Beinart C, Bleich A, Su S, Kim M, Toniolo PG: A nested case-control study of mammographic patterns, breast volume, and breast cancer (New York City, NY, United States). Cancer Causes Control. 1995, 6: 431-438. 10.1007/BF00052183.CrossRefPubMed Kato I, Beinart C, Bleich A, Su S, Kim M, Toniolo PG: A nested case-control study of mammographic patterns, breast volume, and breast cancer (New York City, NY, United States). Cancer Causes Control. 1995, 6: 431-438. 10.1007/BF00052183.CrossRefPubMed
9.
go back to reference Ursin G, Longnecker MP, Haile RW, Greenland S: A meta-analysis of body mass index and risk of premenopausal breast cancer. Epidemiology. 1995, 6: 137-141. 10.1097/00001648-199503000-00009.CrossRefPubMed Ursin G, Longnecker MP, Haile RW, Greenland S: A meta-analysis of body mass index and risk of premenopausal breast cancer. Epidemiology. 1995, 6: 137-141. 10.1097/00001648-199503000-00009.CrossRefPubMed
10.
go back to reference Byrne C, Schairer C, Wolfe J, Parekh N, Salane M, Brinton LA, Hoover R, Haile R: Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst. 1995, 87: 1622-1629. 10.1093/jnci/87.21.1622.CrossRefPubMed Byrne C, Schairer C, Wolfe J, Parekh N, Salane M, Brinton LA, Hoover R, Haile R: Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst. 1995, 87: 1622-1629. 10.1093/jnci/87.21.1622.CrossRefPubMed
11.
go back to reference Wong CS, Lim GH, Gao F, Jakes RW, Offman J, Chia KS, Duffy SW: Mammographic density and its interaction with other breast cancer risk factors in an Asian population. Br J Cancer. 2011, 104: 871-874. 10.1038/sj.bjc.6606085.CrossRefPubMedPubMedCentral Wong CS, Lim GH, Gao F, Jakes RW, Offman J, Chia KS, Duffy SW: Mammographic density and its interaction with other breast cancer risk factors in an Asian population. Br J Cancer. 2011, 104: 871-874. 10.1038/sj.bjc.6606085.CrossRefPubMedPubMedCentral
12.
go back to reference Chamras H, Bagga D, Elstner E, Setoodeh K, Koeffler HP, Heber D: Preadipocytes stimulate breast cancer cell growth. Nutr Cancer. 1998, 32: 59-63. 10.1080/01635589809514719.CrossRefPubMed Chamras H, Bagga D, Elstner E, Setoodeh K, Koeffler HP, Heber D: Preadipocytes stimulate breast cancer cell growth. Nutr Cancer. 1998, 32: 59-63. 10.1080/01635589809514719.CrossRefPubMed
13.
go back to reference Roth J, Qiang X, Marban SL, Redelt H, Lowell BC: The obesity pandemic: where have we been and where are we going?. Obes Res. 2004, 12: 88S-101S.CrossRefPubMed Roth J, Qiang X, Marban SL, Redelt H, Lowell BC: The obesity pandemic: where have we been and where are we going?. Obes Res. 2004, 12: 88S-101S.CrossRefPubMed
14.
go back to reference Boyd NF, Martin LJ, Sun L, Guo H, Chiarelli A, Hislop G, Yaffe M, Minkin S: Body size, mammographic density, and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2006, 15: 2086-2092. 10.1158/1055-9965.EPI-06-0345.CrossRefPubMed Boyd NF, Martin LJ, Sun L, Guo H, Chiarelli A, Hislop G, Yaffe M, Minkin S: Body size, mammographic density, and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2006, 15: 2086-2092. 10.1158/1055-9965.EPI-06-0345.CrossRefPubMed
15.
go back to reference Ursin G, Ma H, Wu AH, Bernstein L, Salane M, Parisky YR, Astrahan M, Siozon CC, Pike MC: Mammographic density and breast cancer in three ethnic groups. Cancer Epidemiol Biomarkers Prev. 2003, 12: 332-338.PubMed Ursin G, Ma H, Wu AH, Bernstein L, Salane M, Parisky YR, Astrahan M, Siozon CC, Pike MC: Mammographic density and breast cancer in three ethnic groups. Cancer Epidemiol Biomarkers Prev. 2003, 12: 332-338.PubMed
16.
go back to reference Maskarinec G, Pagano I, Lurie G, Wilkens LR, Kolonel LN: Mammographic density and breast cancer risk: the multiethnic cohort study. Am J Epidemiol. 2005, 162: 743-752. 10.1093/aje/kwi270.CrossRefPubMed Maskarinec G, Pagano I, Lurie G, Wilkens LR, Kolonel LN: Mammographic density and breast cancer risk: the multiethnic cohort study. Am J Epidemiol. 2005, 162: 743-752. 10.1093/aje/kwi270.CrossRefPubMed
17.
go back to reference Duffy SW, Jakes RW, Ng FC, Gao F: Interaction of dense breast patterns with other breast cancer risk factors in a case-control study. Br J Cancer. 2004, 91: 233-236.PubMedPubMedCentral Duffy SW, Jakes RW, Ng FC, Gao F: Interaction of dense breast patterns with other breast cancer risk factors in a case-control study. Br J Cancer. 2004, 91: 233-236.PubMedPubMedCentral
18.
go back to reference Stuedal A, Ma H, Bernstein L, Pike MC, Ursin G: Does breast size modify the association between mammographic density and breast cancer risk?. Cancer Epidemiol Biomarkers Prev. 2008, 17: 621-627. 10.1158/1055-9965.EPI-07-2554.CrossRefPubMed Stuedal A, Ma H, Bernstein L, Pike MC, Ursin G: Does breast size modify the association between mammographic density and breast cancer risk?. Cancer Epidemiol Biomarkers Prev. 2008, 17: 621-627. 10.1158/1055-9965.EPI-07-2554.CrossRefPubMed
19.
go back to reference Stone J, Ding J, Warren RM, Duffy SW, Hopper JL: Using mammographic density to predict breast cancer risk: dense area or percent dense area. Breast Cancer Res. 2010, 12: R97-10.1186/bcr2778.CrossRefPubMedPubMedCentral Stone J, Ding J, Warren RM, Duffy SW, Hopper JL: Using mammographic density to predict breast cancer risk: dense area or percent dense area. Breast Cancer Res. 2010, 12: R97-10.1186/bcr2778.CrossRefPubMedPubMedCentral
20.
go back to reference Johnston PG, Rondinone CM, Voeller D, Allegra CJ: Identification of a protein factor secreted by 3T3-L1 preadipocytes inhibitory for the human MCF-7 breast cancer cell line. Cancer Res. 1992, 52: 6860-6865.PubMed Johnston PG, Rondinone CM, Voeller D, Allegra CJ: Identification of a protein factor secreted by 3T3-L1 preadipocytes inhibitory for the human MCF-7 breast cancer cell line. Cancer Res. 1992, 52: 6860-6865.PubMed
21.
go back to reference Iyengar P, Espina V, Williams TW, Lin Y, Berry D, Jelicks LA, Lee H, Temple K, Graves R, Pollard J, Chopra N, Russell RG, Sasisekharan R, Trock BJ, Lippman M, Calvert VS, Petricoin EF, Liotta L, Dadachova E, Pestell RG, Lisanti MP, Bonaldo P, Scherer PE: Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment. J Clin Invest. 2005, 115: 1163-1176.CrossRefPubMedPubMedCentral Iyengar P, Espina V, Williams TW, Lin Y, Berry D, Jelicks LA, Lee H, Temple K, Graves R, Pollard J, Chopra N, Russell RG, Sasisekharan R, Trock BJ, Lippman M, Calvert VS, Petricoin EF, Liotta L, Dadachova E, Pestell RG, Lisanti MP, Bonaldo P, Scherer PE: Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment. J Clin Invest. 2005, 115: 1163-1176.CrossRefPubMedPubMedCentral
22.
go back to reference Iyengar P, Combs TP, Shah SJ, Gouon-Evans V, Pollard JW, Albanese C, Flanagan L, Tenniswood MP, Guha C, Lisanti MP, Pestell RG, Scherer PE: Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization. Oncogene. 2003, 22: 6408-6423. 10.1038/sj.onc.1206737.CrossRefPubMed Iyengar P, Combs TP, Shah SJ, Gouon-Evans V, Pollard JW, Albanese C, Flanagan L, Tenniswood MP, Guha C, Lisanti MP, Pestell RG, Scherer PE: Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization. Oncogene. 2003, 22: 6408-6423. 10.1038/sj.onc.1206737.CrossRefPubMed
23.
go back to reference Rahimi N, Saulnier R, Nakamura T, Park M, Elliott B: Role of hepatocyte growth factor in breast cancer: a novel mitogenic factor secreted by adipocytes. DNA Cell Biol. 1994, 13: 1189-1197. 10.1089/dna.1994.13.1189.CrossRefPubMed Rahimi N, Saulnier R, Nakamura T, Park M, Elliott B: Role of hepatocyte growth factor in breast cancer: a novel mitogenic factor secreted by adipocytes. DNA Cell Biol. 1994, 13: 1189-1197. 10.1089/dna.1994.13.1189.CrossRefPubMed
24.
go back to reference Szymczak J, Milewicz A, Thijssen JH, Blankenstein MA, Daroszewski J: Concentration of sex steroids in adipose tissue after menopause. Steroids. 1998, 63: 319-321. 10.1016/S0039-128X(98)00019-1.CrossRefPubMed Szymczak J, Milewicz A, Thijssen JH, Blankenstein MA, Daroszewski J: Concentration of sex steroids in adipose tissue after menopause. Steroids. 1998, 63: 319-321. 10.1016/S0039-128X(98)00019-1.CrossRefPubMed
25.
go back to reference Thijssen JH: Local biosynthesis and metabolism of oestrogens in the human breast. Maturitas. 2004, 49: 25-33. 10.1016/j.maturitas.2004.06.004.CrossRefPubMed Thijssen JH: Local biosynthesis and metabolism of oestrogens in the human breast. Maturitas. 2004, 49: 25-33. 10.1016/j.maturitas.2004.06.004.CrossRefPubMed
26.
27.
go back to reference Purohit A, Reed MJ: Regulation of estrogen synthesis in postmenopausal women. Steroids. 2002, 67: 979-983. 10.1016/S0039-128X(02)00046-6.CrossRefPubMed Purohit A, Reed MJ: Regulation of estrogen synthesis in postmenopausal women. Steroids. 2002, 67: 979-983. 10.1016/S0039-128X(02)00046-6.CrossRefPubMed
28.
go back to reference Boker LK, van Noord PA, van der Schouw YT, Koot NV, Bueno de Mesquita HB, Riboli E, Grobbee DE, Peeters PH: Prospect-EPIC Utrecht: study design and characteristics of the cohort population. european prospective investigation into cancer and nutrition. Eur J Epidemiol. 2001, 17: 1047-1053. 10.1023/A:1020009325797.CrossRefPubMed Boker LK, van Noord PA, van der Schouw YT, Koot NV, Bueno de Mesquita HB, Riboli E, Grobbee DE, Peeters PH: Prospect-EPIC Utrecht: study design and characteristics of the cohort population. european prospective investigation into cancer and nutrition. Eur J Epidemiol. 2001, 17: 1047-1053. 10.1023/A:1020009325797.CrossRefPubMed
29.
go back to reference Beulens JW, Monninkhof EM, Verschuren WM, van der Schouw YT, Smit J, Ocke MC, Jansen EH, van Dieren S, Grobbee DE, Peeters PH, Bueno-de-Mesquita HB: Cohort profile: the EPIC-NL study. Int J Epidemiol. 2009, 39: 1170-1178.CrossRefPubMed Beulens JW, Monninkhof EM, Verschuren WM, van der Schouw YT, Smit J, Ocke MC, Jansen EH, van Dieren S, Grobbee DE, Peeters PH, Bueno-de-Mesquita HB: Cohort profile: the EPIC-NL study. Int J Epidemiol. 2009, 39: 1170-1178.CrossRefPubMed
30.
go back to reference Riboli E, Kaaks R: The EPIC Project: rationale and study design. european prospective investigation into cancer and nutrition. Int J Epidemiol. 1997, 26: S6-14. 10.1093/ije/26.suppl_1.S6.CrossRefPubMed Riboli E, Kaaks R: The EPIC Project: rationale and study design. european prospective investigation into cancer and nutrition. Int J Epidemiol. 1997, 26: S6-14. 10.1093/ije/26.suppl_1.S6.CrossRefPubMed
31.
go back to reference Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, Charrondiere UR, Hemon B, Casagrande C, Vignat J, Overvad K, Tjonneland A, Clavel-Chapelon F, Thiebaut A, Wahrendorf J, Boeing H, Trichopoulos D, Trichopoulou A, Vineis P, Palli D, Bueno-de-Mesquita HB, Peeters PH, Lund E, Engeset D, Gonzalez CA, Barricarte A, Berglund G, Hallmans G, Day NE, Key TJ, et al: European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr. 2002, 5: 1113-1124. 10.1079/PHN2002394.CrossRefPubMed Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, Charrondiere UR, Hemon B, Casagrande C, Vignat J, Overvad K, Tjonneland A, Clavel-Chapelon F, Thiebaut A, Wahrendorf J, Boeing H, Trichopoulos D, Trichopoulou A, Vineis P, Palli D, Bueno-de-Mesquita HB, Peeters PH, Lund E, Engeset D, Gonzalez CA, Barricarte A, Berglund G, Hallmans G, Day NE, Key TJ, et al: European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr. 2002, 5: 1113-1124. 10.1079/PHN2002394.CrossRefPubMed
32.
go back to reference Grobbee DE, Hoes AW: Case-control studies. 2008, Sudbury, MA, USA: Jones & Bartlett Publishers, 226-269. Grobbee DE, Hoes AW: Case-control studies. 2008, Sudbury, MA, USA: Jones & Bartlett Publishers, 226-269.
33.
go back to reference Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ: The quantitative analysis of mammographic densities. Phys Med Biol. 1994, 39: 1629-1638. 10.1088/0031-9155/39/10/008.CrossRefPubMed Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ: The quantitative analysis of mammographic densities. Phys Med Biol. 1994, 39: 1629-1638. 10.1088/0031-9155/39/10/008.CrossRefPubMed
34.
go back to reference Martin LJ, Boyd NF: Mammographic density. potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence. Breast Cancer Res. 2008, 10: 201-10.1186/bcr1831.CrossRefPubMedPubMedCentral Martin LJ, Boyd NF: Mammographic density. potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence. Breast Cancer Res. 2008, 10: 201-10.1186/bcr1831.CrossRefPubMedPubMedCentral
35.
go back to reference Verheus M, Peeters PH, van Noord PA, van der Schouw YT, Grobbee DE, van Gils CH: No relationship between circulating levels of sex steroids and mammographic breast density: the Prospect-EPIC cohort. Breast Cancer Res. 2007, 9: R53-10.1186/bcr1758.CrossRefPubMedPubMedCentral Verheus M, Peeters PH, van Noord PA, van der Schouw YT, Grobbee DE, van Gils CH: No relationship between circulating levels of sex steroids and mammographic breast density: the Prospect-EPIC cohort. Breast Cancer Res. 2007, 9: R53-10.1186/bcr1758.CrossRefPubMedPubMedCentral
36.
go back to reference Tamimi RM, Byrne C, Colditz GA, Hankinson SE: Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst. 2007, 99: 1178-1187. 10.1093/jnci/djm062.CrossRefPubMed Tamimi RM, Byrne C, Colditz GA, Hankinson SE: Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst. 2007, 99: 1178-1187. 10.1093/jnci/djm062.CrossRefPubMed
37.
go back to reference Vachon CM, Sasano H, Ghosh K, Brandt KR, Watson DA, Reynolds C, Lingle WL, Goss PE, Li R, Aiyar SE, Scott CG, Pankratz VS, Santen RJ, Ingle JN: Aromatase immunoreactivity is increased in mammographically dense regions of the breast. Breast Cancer Res Treat. 2011, 125: 243-252. 10.1007/s10549-010-0944-6.CrossRefPubMed Vachon CM, Sasano H, Ghosh K, Brandt KR, Watson DA, Reynolds C, Lingle WL, Goss PE, Li R, Aiyar SE, Scott CG, Pankratz VS, Santen RJ, Ingle JN: Aromatase immunoreactivity is increased in mammographically dense regions of the breast. Breast Cancer Res Treat. 2011, 125: 243-252. 10.1007/s10549-010-0944-6.CrossRefPubMed
38.
go back to reference Cleary MP, Grossmann ME, Ray A: Effect of obesity on breast cancer development. Vet Pathol. 2010, 47: 202-213. 10.1177/0300985809357753.CrossRefPubMed Cleary MP, Grossmann ME, Ray A: Effect of obesity on breast cancer development. Vet Pathol. 2010, 47: 202-213. 10.1177/0300985809357753.CrossRefPubMed
39.
go back to reference Grossmann ME, Ray A, Nkhata KJ, Malakhov DA, Rogozina OP, Dogan S, Cleary MP: Obesity and breast cancer: status of leptin and adiponectin in pathological processes. Cancer Metastasis Rev. 2010, 29: 641-653. 10.1007/s10555-010-9252-1.CrossRefPubMed Grossmann ME, Ray A, Nkhata KJ, Malakhov DA, Rogozina OP, Dogan S, Cleary MP: Obesity and breast cancer: status of leptin and adiponectin in pathological processes. Cancer Metastasis Rev. 2010, 29: 641-653. 10.1007/s10555-010-9252-1.CrossRefPubMed
40.
go back to reference Boyd NF, Rommens JM, Vogt K, Lee V, Hopper JL, Yaffe MJ, Paterson AD: Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol. 2005, 6: 798-808. 10.1016/S1470-2045(05)70390-9.CrossRefPubMed Boyd NF, Rommens JM, Vogt K, Lee V, Hopper JL, Yaffe MJ, Paterson AD: Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol. 2005, 6: 798-808. 10.1016/S1470-2045(05)70390-9.CrossRefPubMed
41.
go back to reference Lokate M, Kallenberg MG, Karssemeijer N, Van den Bosch MA, Peeters PH, van Gils CH: Volumetric breast density from full-field digital mammograms and its association with breast cancer risk factors: a comparison with a threshold method. Cancer Epidemiol Biomarkers Prev. 2010, 19: 3096-3105. 10.1158/1055-9965.EPI-10-0703.CrossRefPubMed Lokate M, Kallenberg MG, Karssemeijer N, Van den Bosch MA, Peeters PH, van Gils CH: Volumetric breast density from full-field digital mammograms and its association with breast cancer risk factors: a comparison with a threshold method. Cancer Epidemiol Biomarkers Prev. 2010, 19: 3096-3105. 10.1158/1055-9965.EPI-10-0703.CrossRefPubMed
Metadata
Title
Mammographic density and breast cancer risk: the role of the fat surrounding the fibroglandular tissue
Authors
Mariëtte Lokate
Petra HM Peeters
Linda M Peelen
Gerco Haars
Wouter B Veldhuis
Carla H van Gils
Publication date
01-10-2011
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 5/2011
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr3044

Other articles of this Issue 5/2011

Breast Cancer Research 5/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine